Effect of pretreatment with pyridostigmine on the thyrotropin response to thyrotropin-releasing hormone in patients with Cushing's disease.
Giustina
A
A
Cattedra di Clinica Medica, University of Brescia, Italy.
Bossoni
S
S
Buffoli
M G
MG
Ferrari
C
C
Pozzi
A
A
Scalvini
T
T
Schettino
M
M
D000236:Adenoma / Q000097:blood; D000328:Adult; D003480:Cushing Syndrome / Q000097:blood*; D004347:Drug Interactions; D005260:Female; D006801:Humans; D008875:Middle Aged; D010911:Pituitary Neoplasms / Q000097:blood; D011729:Pyridostigmine Bromide / Q000494:pharmacology*; D011863:Radioimmunoassay; D013972:Thyrotropin / Q000097:blood*; D013973:Thyrotropin-Releasing Hormone / Q000494:pharmacology*
D013973:Thyrotropin-Releasing Hormone; D013972:Thyrotropin; D011729:Pyridostigmine Bromide